As the first line of defence, marginal zone (MZ) B cells play principal roles in clearing blood-borne pathogens during infection and are over-primed in autoimmune diseases. However, the basic mechanisms underlying MZ B-cell development are still unclear. We found here that CD19 deficiency blocked the differentiation of marginal zone precursors (MZP) to MZ B cells, whereas CD19 expression in CD19-deficient MZP rescues MZ B-cell generation. Furthermore, CD19 regulates Notch2 cleavage by up-regulating ADAM28 expression in MZP. Finally, we found that CD19 suppressed Foxo1 expression to promote ADAM28 expression in MZP. These results suggest that CD19 controls the differentiation of MZP to MZ B cells by regulating ADAM28-mediated Notch2 cleavage. Thus, we demonstrated the basic mechanisms underlying the differentiation of MZP to MZ B cells.
[1]Inst Basic Med Sci, Immunol Lab, Beijing, Peoples R China.
[2]Henan Univ, Coll Pharm, Kaifeng, Peoples R China.
[3]Henan Univ, Lab Cellular & Mol Immunol, Kaifeng, Henan, Peoples R China.
[4]Chinese Peoples Liberat Army, Dept Nephrol, Hosp 307, Dept Nephrol, Beijing, Peoples R China.
[5]Jilin Univ, Dept Rheumatol, Hosp 1, Changchun, Jilin, Peoples R China.
(8.0+极速模式)